Use the Search Fields to Find Information
Page 52 of 360
The acute effects of vaporized cannabis on drivers’ hazard perception and risk-taking behaviors in medicinal patients: A within-subjects experiment
Abstract Introduction: As the medically prescribed use of cannabis flower continues to increase, there is a need to understand how vaporized cannabis can acutely affect
April 17, 2025
The acute effects of vaporized cannabis on drivers’ hazard perception and risk-taking behaviors in medicinal patients: A within-subjects experiment
Abstract Introduction: As the medically prescribed use of cannabis flower continues to increase, there is a need to understand how vaporized cannabis can acutely affect
April 23, 2025
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
Abstract Rationale There is growing interest in the therapeutic potential of cannabidiol (CBD) across a range of psychiatric disorders. CBD has been found to reduce
January 18, 2024
The acute and non-acute effects of cannabis on reward processing: A systematic review
Please use this link to access this publication. Abstract Cannabis use has historically been thought to cause amotivation, but the relationship between cannabis and apathy, anhedonia,
August 23, 2025
The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
Abstract Cannabidiol (CBD), the major nonpsychoactive Cannabis constituent, has been proposed for the treatment of a wide panel of neurological and neuropsychiatric disorders, including anxiety,
April 24, 2024
The (endo)cannabinoid signaling in female reproduction: What are the latest advances?
Please use this link to access this publication. Abstract Cannabis extracts like marijuana have the highest consumption rate worldwide. Yet, their societal acceptance as recreational
August 30, 2025
The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
Abstract Mood disorders are the most prevalent mental conditions encountered in psychiatric practice. Numerous patients suffering from mood disorders present with treatment-resistant forms of depression,
November 22, 2023
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms
Background: The prospective observational MObility ImproVEment (MOVE) 2 study is collecting real-life clinical outcomes data on patients with treatment-resistant multiple sclerosis (MS) spasticity treated with
September 19, 2019
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain
Abstract Background: From the time Sativex (THC:CBD) oromucosal spray first became available in European Union countries in 2010 for the management of treatment-resistant multiple sclerosis (MS)
September 4, 2024
THC Regulates Tearing via Cannabinoid CB1 Receptors
Abstract Purpose: Aqueous deficiency dry eye (ADDE) is a chronic condition affecting millions, with symptoms ranging from a dry itchiness to blurred vision and accompanied by
May 31, 2024
Page 52 of 360